Epidemiologic and environmental characterization of the Re-emergence of St. Louis Encephalitis Virus in California, 2015-2020.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
08 2022
Historique:
received: 16 05 2022
accepted: 15 07 2022
revised: 18 08 2022
pubmed: 9 8 2022
medline: 23 8 2022
entrez: 8 8 2022
Statut: epublish

Résumé

St. Louis encephalitis virus (SLEV) is an endemic flavivirus in the western and southeastern United States, including California. From 1938 to 2003, the virus was detected annually in California, but after West Nile virus (WNV) arrived in 2003, SLEV was not detected again until it re-emerged in Riverside County in 2015. The re-emerging virus in California and other areas of the western US is SLEV genotype III, which previously had been detected only in Argentina, suggesting a South American origin. This study describes SLEV activity in California since its re-emergence in 2015 and compares it to WNV activity during the same period. From 2015 to 2020, SLEV was detected in 1,650 mosquito pools and 26 sentinel chickens, whereas WNV was detected concurrently in 18,108 mosquito pools and 1,542 sentinel chickens from the same samples. There were 24 reported human infections of SLEV in 10 California counties, including two fatalities (case fatality rate: 8%), compared to 2,469 reported human infections of WNV from 43 California counties, with 143 fatalities (case fatality rate: 6%). From 2015 through 2020, SLEV was detected in 17 (29%) of California's 58 counties, while WNV was detected in 54 (93%). Although mosquitoes and sentinel chickens have been tested routinely for arboviruses in California for over fifty years, surveillance has not been uniform throughout the state. Of note, since 2005 there has been a steady decline in the use of sentinel chickens among vector control agencies, potentially contributing to gaps in SLEV surveillance. The incidence of SLEV disease in California may have been underestimated because human surveillance for SLEV relied on an environmental detection to trigger SLEV patient screening and mosquito surveillance effort is spatially variable. In addition, human diagnostic testing usually relies on changes in host antibodies and SLEV infection can be indistinguishable from infection with other flaviviruses such as WNV, which is more prevalent.

Identifiants

pubmed: 35939506
doi: 10.1371/journal.pntd.0010664
pii: PNTD-D-22-00638
pmc: PMC9387929
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010664

Subventions

Organisme : NCEZID CDC HHS
ID : U01 CK000516
Pays : United States
Organisme : NCEH CDC HHS
ID : U01 EH000418
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Med Entomol. 1995 May;32(3):255-66
pubmed: 7616515
J Clin Microbiol. 2001 Dec;39(12):4506-13
pubmed: 11724870
Am J Trop Med Hyg. 2018 Oct;99(4):1074-1079
pubmed: 30182919
J Med Entomol. 2015 May;52(3):491-9
pubmed: 26334826
J Med Entomol. 2019 Oct 28;56(6):1508-1515
pubmed: 31549727
Am J Trop Med Hyg. 2006 Sep;75(3):480-5
pubmed: 16968925
J Vector Ecol. 2008 Jun;33(1):89-98
pubmed: 18697311
Emerg Infect Dis. 2002 Mar;8(3):245-51
pubmed: 11927020
Viruses. 2013 Sep 25;5(10):2329-48
pubmed: 24072061
Int J Health Geogr. 2004 Apr 20;3(1):8
pubmed: 15099399
PLoS Negl Trop Dis. 2021 Jul 6;15(7):e0009535
pubmed: 34228748
J Med Entomol. 2008 May;45(3):494-508
pubmed: 18533445
Emerg Infect Dis. 2016 Dec;22(12):2185-2188
pubmed: 27869600
Science. 1941 Oct 3;94(2440):328-30
pubmed: 17836027
J Med Entomol. 2017 May 1;54(3):533-543
pubmed: 28399270
Am J Public Health Nations Health. 1939 Oct;29(10):1083-97
pubmed: 18015115
J Am Mosq Control Assoc. 1994 Dec;10(4):549-55
pubmed: 7707063
Calif Med. 1951 Sep;75(3):189-95
pubmed: 14870034
Am J Trop Med Hyg. 2007 Jul;77(1):159-63
pubmed: 17620648
J Hyg (Lond). 1972 Dec;70(4):611-7
pubmed: 4509639
J Med Entomol. 2003 Nov;40(6):968-82
pubmed: 14765678
Vector Borne Zoonotic Dis. 2016 Apr;16(4):264-82
pubmed: 26974395
Am J Public Health Nations Health. 1939 Jul;29(7):781-6
pubmed: 18015077
J Med Entomol. 2002 Sep;39(5):793-805
pubmed: 12349864
PLoS Negl Trop Dis. 2020 Jun 10;14(6):e0008343
pubmed: 32520944
Front Microbiol. 2018 Oct 11;9:2421
pubmed: 30369916
PLoS Negl Trop Dis. 2020 Nov 18;14(11):e0008841
pubmed: 33206634
Am J Trop Med Hyg. 1997 Nov;57(5):526-9
pubmed: 9392590
MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1349-50
pubmed: 26656306
Adv Virus Res. 2003;61:139-83
pubmed: 14714432
Front Genet. 2021 Jun 08;12:667895
pubmed: 34168675
J Med Entomol. 2004 Sep;41(5):965-72
pubmed: 15535629
Public Health Rep (1896). 1958 Apr;73(4):340-53
pubmed: 13542726
Expert Rev Anti Infect Ther. 2015 Mar;13(3):327-42
pubmed: 25641365
Am J Trop Med Hyg. 2008 Mar;78(3):434-41
pubmed: 18337340
Am J Trop Med Hyg. 1997 Aug;57(2):222-9
pubmed: 9288820
J Med Entomol. 2005 May;42(3):367-75
pubmed: 15962789
J Clin Microbiol. 2000 May;38(5):1823-6
pubmed: 10790107
J Med Entomol. 1992 May;29(3):472-82
pubmed: 1625296
Pathog Glob Health. 2020 Oct;114(7):345-346
pubmed: 32845819

Auteurs

Mary E Danforth (ME)

California Department of Public Health, Vector-Borne Disease Section, Richmond and Sacramento, California.

Robert E Snyder (RE)

California Department of Public Health, Vector-Borne Disease Section, Richmond and Sacramento, California.

Tina Feiszli (T)

California Department of Public Health, Vector-Borne Disease Section, Richmond and Sacramento, California.

Teal Bullick (T)

California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California.

Sharon Messenger (S)

California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California.

Carl Hanson (C)

California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California.

Kerry Padgett (K)

California Department of Public Health, Vector-Borne Disease Section, Richmond and Sacramento, California.

Lark L Coffey (LL)

Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California, United States of America.

Christopher M Barker (CM)

Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California, United States of America.

William K Reisen (WK)

Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California, United States of America.

Vicki L Kramer (VL)

California Department of Public Health, Vector-Borne Disease Section, Richmond and Sacramento, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH